Publications
1
S. Zawadzki, Á. Martín‑Serrano, E. Okła, M. Kędzierska, S. Garcia‑Gallego, P.O. López, F.J. de la Mata, S. Michlewska, T. Makowski, M. Ionov, E. Pędziwiatr‑Werbicka, M. Bryszewska, Katarzyna Miłowska. Synthesis and biophysical evaluation of carbosilane dendrimers as therapeutic siRNA carriers. Sci. Reports (2024) 14:1615. https://doi.org/10.1038/s41598-024-51238-w
3
Chałubiński M., Szulc A., Gorzelak-Pabiś P., Wojdan K., Appelhans D., Bryszewska M., Broncel M.: The effect of maltose modified fourth generation poly(propylene imine) (PPI G4) dendrimers on the barrier functions and inflammatory activation of human vascular endothelium – Possible consequences for the medical application. Vascular Pharmacol. 143, DOI:10.1016/j.vph.2022.106972, 2022
5
N. Sanz del Olmo, M. Maroto-Diaz, S. Quintana, R. Gomez, M. Hołota, M. Ionov, M. Bryszewska, M. Jose Carmena, P. Ortega, F. J. de la Mata: Heterofunctional ruthenium(II) carbosilane dendrons, a new class of dendritic molecules to fight against prostate cancer, Eur. J. Med. Chem. 27, DOI: 10.1016/j.ejmech.2020.112695, 2020
7
S. Michlewska, M. Ionov, A. Szwed, A. Rogalska, N. Sanz del Olmo, P. Ortega, M. Denel, D. Jacenik, D. Shcharbin, F. J. de la Mata, M. Bryszewska: Ruthenium dendrimers against human lymphoblastic leukemia 1301 cells. Int. J. Mol. Sci. 21, DOI: 10.3390/ijms21114119, 2020
9
N. Sanz del Olmo, A. Bajo, M. Ionov, S. Garcia-Gallego, M. Bryszewska, R. Gomez, P. Ortega, F.J. de la Mata: Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer. Eur. J. Med. Chem. 199, DOI: 10.1016/j.ejmech.2020.112414, 2020
2
E. Okła, P. Białecki, M. Kiędzierska, E. Pedziwiatr-Werbicka, K. Milowska, S. Takvor, R. Gómez Ramírez, F. J. De la Mata, M. Bryszewska, M. Ionov. Pegylated Gold Nanoparticles   Conjugated with siRNA: Complexes Formation and Cytotoxicity. Int. J. Mol. Sci. 24 (2023) 6638. IF, 5.67, MiEN, 140. https://doi.org/10.3390/ijms24076638http://nanotendo.pl/1_3_achievements.html?
4
Kuc-Ciepluch D., Gorzkiewicz M., Pędziwiatr-Werbicka E., Barrios-Gumiel A., Lasak M., Mariak A., Sztandera K., Gomez R., Klajnert-Maculewicz B., Bryszewska M.: The effect of surface modification of dendronized gold nanoparticles on activation and release of pyroptosis-inducing pro-inflammatory cytokines in presence of bacterial lipopolysaccharide in monocytes. Coll. Surf. B-Biointerfaces 217, DOI:10.1016/j.colsurfb.2022.112652, 2022
6
Pędziwiatr-Werbicka, M. Gorzkiewicz, K. Horodecka, D. Lach, A. Barrios-Gumiel, J. Sanchez-Nieves, R. Gomez, F. J. de la Mata, M. Bryszewska: PEGylation of Dendronized Gold Nanoparticles Affects Their Interaction with Thrombin and siRNA, J. Phys. Chem. B. 125, DOI: 10.1021/acs.jpc b.0c10177, 2021
8
N. Sanz del Olmo, M. Hołota, S. Michlewska, R. Gómez, P. Ortega, M. Ionov, F. J. de la Mata, M. Bryszewska: Copper (II) metallodendrimers combined with pro- apaoptotic siRNAs as a promising strategy against breast cancer cells. Pharmaceutics 12, DOI: 10.3390/pharmaceutics12080727, 2020
Conferences
Visits
Trainings
This site, and its content with confidential information that is intended for the exclusive use of NanoTENDO project partners and other authorized persons. Only authorized employees and partners are permitted to access this web site and any unauthorized use of given information is unlawful. The information and material contained on this site is confidential, and all authorized persons accessing the material have an obligation of confidentiality. If you are not an authorized employee or partner of the NanoTENDO project, you are hereby notified that any entry into this site or disclosure, copying, distribution or use of any of the information contained in or attached to this site is strictly prohibited. If you have any knowledge of attempts to enter this site wrongfully, please immediately notify us via e-mail at maksim.ionov@biol.uni.lodz.pl
Copyright ©2020 NanoTENDO, All Rights Reserved.